Verizon vs Johnson & Johnson: Which Dividend Hike Winner Is the Better Buy?

Photo of Trey Thoelcke
By Trey Thoelcke Published

Quick Read

  • Verizon (VZ) offers a 5.8% yield but carries $158B in debt. Johnson & Johnson (JNJ) provides a 2.1% yield with stronger growth.

  • Verizon’s dividend grew 2.04% annually over the past decade. Johnson & Johnson’s dividend expanded 4.7% annually over 27 years.

  • Johnson & Johnson’s Q4 revenue climbed 9.1% year-over-year to $24.56B. Verizon’s wireless service revenue grew 1.1%.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Verizon vs Johnson & Johnson: Which Dividend Hike Winner Is the Better Buy?

© Take Production Studios / Shutterstock.com

Verizon (NYSE: VZ | VZ Price Prediction) and Johnson & Johnson (NYSE: JNJ) both rewarded shareholders with dividend increases this quarter, but their paths to sustaining those payouts look very different. Verizon raised its quarterly dividend to $0.69 per share, marking its 19th consecutive annual raise. Johnson & Johnson lifted its quarterly payout to $1.30 per share, extending a Dividend King streak spanning 63+ consecutive years. Verizon climbed 25.75% over the past month while Johnson & Johnson gained 11.28%.

Diverging Business Models, Different Dividend Foundations

Verizon’s telecom business generates steady cash but carries heavy infrastructure costs. The company produced $20.1 billion in free cash flow in 2025, covering its $11.5 billion dividend 1.75 times. That coverage is healthy, but a $158 billion debt load from the Frontier acquisition constrains flexibility. Capital expenditures consumed $17 billion, reflecting the capital-intensive nature of fiber and wireless infrastructure. CEO Dan Schulman said the company is “exiting 2025 with strong momentum” and promised Verizon “will no longer be a hunting ground for our competitors.” Wireless service revenue grew 1.1% year-over-year, though postpaid phone net adds of 616,000 were the highest quarterly total since 2019.

Johnson & Johnson operates a fundamentally different business. The healthcare giant generated $19.7 billion in free cash flow in 2025 while spending only $4.8 billion on capital expenditures, leaving room for $12.4 billion in dividends plus $6 billion in share buybacks. The payout ratio sits at a comfortable 62.8% of free cash flow. CEO Joaquin Duato called 2025 “a catapult year” driven by the “strongest portfolio and pipeline in our history.” Q4 revenue climbed 9.1% year-over-year to $24.56 billion, with oncology drugs like Darzalex and cardiovascular devices powering growth across Innovative Medicine and MedTech.

Yield Versus Growth: Two Paths Forward

Verizon offers a 5.8% dividend yield, more than double Johnson & Johnson’s 2.1%. But that income advantage has trade-offs. Verizon’s dividend has grown at a 2.04% annual rate over the past decade, barely outpacing inflation. Johnson & Johnson’s dividend expanded at a 4.7% annual clip over 27 years, with recent increases running 4% to 6% annually. Johnson & Johnson trades at 22x trailing earnings versus Verizon’s 12x, reflecting investor confidence in its innovation pipeline.

Metric Verizon Johnson & Johnson
Dividend Yield 5.8% 2.1%
FCF Coverage 1.75x 1.59x
Total Debt $158B Lower (cleaner balance sheet)
10-Year Dividend CAGR 2.04% ~4.7%

Comparing Total Return Potential

Verizon’s 2026 free cash flow guidance of $21.5 billion suggests the payout is sustainable, though the $158 billion debt load and single-digit revenue growth limit upside. Johnson & Johnson’s 63-year track record survived multiple recessions without a cut, and projected EPS growth of 6.9% for 2026 could support continued dividend increases in the 4% to 6% range. Investors weighing the two will find Verizon offers higher current income while Johnson & Johnson has historically delivered faster dividend growth.

 

Photo of Trey Thoelcke
About the Author Trey Thoelcke →

Trey has been an editor and author at 24/7 Wall St. for more than a decade, where he has published thousands of articles analyzing corporate earnings, dividend stocks, short interest, insider buying, private equity, and market trends. His comprehensive coverage spans the full spectrum of financial markets, from blue-chip stalwarts to emerging growth companies.

Beyond 24/7 Wall St., Trey has created and edited financial content for Benzinga and AOL's BloggingStocks, contributing additional hundreds of articles to the investment community. He previously oversaw the 24/7 Climate Insights site, managing editorial operations and content strategy, and currently oversees and creates content for My Investing News.

Trey's editorial expertise extends across multiple publishing environments. He served as production editor at Dearborn Financial Publishing and development editor at Kaplan, where he helped shape financial education materials. Earlier in his career, he worked as a writer-producer at SVE. His freelance editing portfolio includes work for prestigious clients such as Sage Publications, Rand McNally, the Institute for Supply Management, the American Library Association, Eggplant Literary Productions, and Spiegel.

Outside of financial journalism, Trey writes fiction and has been an active member of the writing community for years, overseeing a long-running critique group and moderating workshop sessions at regional conventions. He lives with his family in an old house in the Midwest.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618